Efficacy and safety of evinacumab in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) (NCT04233918)

Paediatric study (age 5-11) investigating pharmacokinetics, efficacy and safety of single and multiple doses of i.v. evinacumab.

Please login or create a FREE account to view this content

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo